NR4A1 and neoplasm: Anti-CCL6, but not anti-CCL9, antibody (Supplemental Figure 17) reduced the recruitment of NK cells (Figure 6J) and prevented tumor regression by MDP in Nr4a1–/– mice (Figure 6K), indicating that I-NCMs promote tumor regression by the CCL6-induced recruitment of NK cells.